Reviva pharmaceuticals to be added to russell microcap® index

Cupertino, calif., june 26, 2023 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), cardiovascular, metabolic, and inflammatory diseases, today announced that the company will be added to the russell microcap® index, effective after the united states market opens on monday, june 26, 2023, following the conclusion of the 2023 russell indexes annual reconstitution.
RVPH Ratings Summary
RVPH Quant Ranking